Semax Reference

Nootropic heptapeptide · Approved in Russia (intranasal); research compound elsewhere

ClassNootropic heptapeptide
StatusApproved in Russia (intranasal); research compound elsewhere
Typical vials5 mg, 10 mg
Dose range200 mcg to 600 mcg
FrequencyDaily, often split morning and midday
Half-lifeNo human data
Dosing unitmicrograms
RouteIntranasal (primary) or subcutaneous

What Semax is

Semax is a Russian-developed heptapeptide derived from a fragment of ACTH with a stabilizing tail, approved in Russia since the 1990s as an intranasal treatment for stroke recovery and cognitive complaints. Outside Russia it has no approvals and circulates as a research nootropic. The Russian clinical literature is substantial but rarely replicated in Western trials, which is the honest caveat on every claim attached to it.

The approved route is intranasal drops, and most community use follows that; injection is a secondary pattern. If you run it intranasally, the intranasal calculator does the sprays-per-bottle and mcg-per-spray math.

Reconstitution math

Concentration is everything: the same 5 mg vial gives a different draw for every amount of bacteriostatic water you add. The table uses the common 2 mL setup for each vial size, which puts every unit on a U-100 insulin syringe at 25 mcg for the default vial. Dashes mark draws too small to measure or larger than the syringe.

VialBAC waterConcentration200 mcg300 mcg600 mcg
5 mg2 mL2.5 mg/mL8 u12 u24 u
10 mg2 mL5 mg/mL4 u6 u12 u
Semax syringe drawsDRAW GUIDEEach dose as a filled syringe5 mg vial + 2 mL bacteriostatic water = 250 mcg per 0.1 mL (10 units).0510152025units on a U-100 insulin syringe (first 25 units shown)200 mcg8 u (0.08 mL)300 mcg12 u (0.12 mL)600 mcg24 u (0.24 mL)peprecon.com
Draw positions for the common doses at the default setup.

Dosing and protocol

Community protocol: 200 to 600 mcg daily, intranasally or subcutaneously, often split into morning and midday doses.

Community dosing is 200 to 600 mcg daily by either route, often split. On a 5 mg vial with 2 mL of water, 300 mcg is a 12-unit draw. The NA-Semax amidate variant circulating in the community is a distinct molecule with its own (even thinner) evidence base; this page covers standard Semax.

Pharmacokinetics

No curve is shown, on purpose.

Semax has no published human pharmacokinetic profile; peptide fragments of it clear the blood in minutes, and its cognitive claims rest on central nervous system effects that outlast plasma levels. Russian approval documentation reports efficacy endpoints, not PK curves usable here.

Storage and handling

Lyophilized vials keep best cold, dark, and dry; refrigeration is the community default and freezing lyophilized powder is common for long holds. After reconstitution, refrigerate at 2 to 8 C, do not freeze the solution, and date the vial. Bacteriostatic water's preservative keeps multi-dose use practical for about 28 days by USP convention, though our 120-day stability study found the preservative itself outlasts that window.

Got a certificate of analysis with your vial? Run it through our COA Reader: it reads the report in plain English, checks purity and mass against the label claim, and links the testing lab’s own verification page. Our guide to reading a COA explains what the numbers do and do not tell you.

Sources

  1. Ashmarin et al., Semax, an analogue of ACTH(4-10): neuroprotective effects, Zh Vyssh Nerv Deiat 1997
  2. Gusev et al., Semax in acute ischemic stroke, Zh Nevrol Psikhiatr 2005

Related references: Selank · DSIP